产前胼胝体发育不全中外显子组测序的诊断检出率:系统评价与Meta分析
该系统评价与Meta分析纳入28项研究共288例产前诊断胼胝体发育不全且染色体微阵列分析阴性的病例,评估外显子组测序的增量诊断检出率。Meta分析纳入15项研究268例,总体致病/可能致病变异检出率为43%;合并颅外异常者最高为55%(95%CI 35-73%),合并其他颅脑异常者为43%(95%CI 30-57%),孤立性胼胝体发育不全为32%(95%CI 18-51%)。结论认为染色体微阵列分析阴性后外显子组测序具有增量诊断价值,孤立性病例也应考虑外显子组测序。
要点
- 产前胼胝体发育不全且CMA阴性时,ES总体P/LP变异检出率为43%。
- 合并颅外异常者ES检出率最高,为55%(95%CI 35-73%)。
- 孤立性胼胝体发育不全ES检出率为32%(95%CI 18-51%),也应考虑ES。
核心结论
- 产前诊断胼胝体发育不全且CMA阴性时,ES具有增量诊断检出率;合并颅外异常和其他中枢神经系统异常者检出率最高,孤立性胼胝体发育不全也应考虑ES。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、SCOPUS、Web of Science和Cochrane Library截至2022年6月发表的英文文献;系统评价纳入28项研究288例产前诊断胼胝体发育不全且CMA阴性后行ES的病例,Meta分析仅纳入报告≥3例胼胝体发育不全病例的15项研究共268例,采用随机效应模型合并比例,并使用改良的诊断准确性报告标准(STARD)标准进行质量评价。
诊断标准与关键数值
- ES对致病/可能致病(P/LP)变异的检出率:全部病例为43%;合并颅外异常者为55%(95%CI 35-73%);合并其他颅脑异常者为43%(95%CI 30-57%);孤立性胼胝体发育不全为32%(95%CI 18-51%)。
临床应用与阅片要点
- 产前超声诊断胼胝体发育不全且CMA阴性时,可考虑行ES;合并颅外异常或其他颅脑异常者ES检出率较高,孤立性胼胝体发育不全者ES检出率为32%(95%CI 18-51%)。
局限性
- Meta分析仅纳入报告≥3例胼胝体发育不全病例的研究,共15项研究268例。
- 系统评价纳入的28项研究共288例,其中仅15项研究268例进入Meta分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine the incremental diagnostic yield of exome sequencing (ES) after negative chromosomal microarray analysis (CMA) in cases of prenatally diagnosed agenesis of the corpus callosum (ACC) and to identify the associated genes and variants.
METHODS: A systematic search was performed to identify relevant studies published up until June 2022 using four databases: PubMed, SCOPUS, Web of Science and The Cochrane Library. Studies in English reporting on the diagnostic yield of ES following negative CMA in prenatally diagnosed partial or complete ACC were included. Authors of cohort studies were contacted for individual participant data and extended cohorts were provided for two of them. The increase in diagnostic yield with ES for pathogenic/likely pathogenic (P/LP) variants was assessed in all cases of ACC, isolated ACC, ACC with other cranial anomalies and ACC with extracranial anomalies. To identify all reported genetic variants, the systematic review included all ACC cases; however, for the meta-analysis, only studies with ≥ three ACC cases were included. Meta-analysis of proportions was employed using a random-effects model. Quality assessment of the included studies was performed using modified Standards for Reporting of Diagnostic Accuracy criteria.
RESULTS: A total of 28 studies, encompassing 288 prenatally diagnosed ACC cases that underwent ES following negative CMA, met the inclusion criteria of the systematic review. We classified 116 genetic variants in 83 genes associated with prenatal ACC with a full phenotypic description. There were 15 studies, encompassing 268 cases, that reported on ≥ three ACC cases and were included in the meta-analysis. Of all the included cases, 43% had a P/LP variant on ES. The highest yield was for ACC with extracranial anomalies (55% (95% CI, 35-73%)), followed by ACC with other cranial anomalies (43% (95% CI, 30-57%)) and isolated ACC (32% (95% CI, 18-51%)).
CONCLUSIONS: ES demonstrated an incremental diagnostic yield in cases of prenatally diagnosed ACC following negative CMA. While the greatest diagnostic yield was observed in ACC with extracranial anomalies and ACC with other central nervous system anomalies, ES should also be considered in cases of isolated ACC. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Mustafa HJ, Barbera JP, Sambatur EV, et al. Diagnostic yield of exome sequencing in prenatal agenesis of corpus callosum: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 37519216. doi:10.1002/uog.27440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。